📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Cardurion Pharmaceuticals

1.1 - Company Overview

Cardurion Pharmaceuticals Logo

Cardurion Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of cardiovascular therapeutics and research services, developing a PDE9 inhibitor for HFrEF and HFpEF to enhance existing therapy; a CaMKII inhibitor for CPVT, heart failure, and atrial fibrillation; and conducting clinical trials, plus medicinal chemistry, computational molecular modeling, and genetic engineering support for cardiovascular research.

Products and services

  • CaMKII Inhibitor: A clinical-stage drug targeting hyperactivated CaMKII, intended to treat CPVT, heart failure, and atrial fibrillation across cardiovascular disease indications
  • Clinical Trials: Investigational research studies designed to evaluate the safety and efficacy of Cardurion's investigational medicines for cardiovascular diseases
  • PDE9 Inhibitor: An adjunctive treatment under development for chronic heart failure (HFrEF and HFpEF), aiming to improve efficacy when added to existing medical therapies

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Cardurion Pharmaceuticals

CardiAQ Valve Technologies Logo

CardiAQ Valve Technologies

HQ: United States Website
  • Description: Provider of innovative heart valve replacement solutions, initially focused on transcatheter mitral valve implantation (TMVI), a minimally invasive catheter-based procedure for replacing the heart's mitral valve.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CardiAQ Valve Technologies company profile →
Dezima Pharma Logo

Dezima Pharma

HQ: The Netherlands Website
  • Description: Provider of protein-based compounds for the treatment of cardiovascular disease related to dyslipidemia; founded in 2012 and based in Naarden, the Netherlands.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dezima Pharma company profile →
Conavi Medical Logo

Conavi Medical

HQ: Canada Website
  • Description: Provider of image guidance technologies for minimally invasive cardiovascular procedures, including catheter-based ultrasound that generates 2-D and 3-D images of intracardiac and intravascular anatomy around the catheter tip, and the Novasight Hybrid System, which combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Conavi Medical company profile →
WR Medical Logo

WR Medical

HQ: United States Website
  • Description: Provider of medical devices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WR Medical company profile →
Bellerophon Therapeutics Logo

Bellerophon Therapeutics

HQ: United States Website
  • Description: Provider of innovative products that combine novel drugs and devices for the treatment of cardiopulmonary diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bellerophon Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Cardurion Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Cardurion Pharmaceuticals

2.2 - Growth funds investing in similar companies to Cardurion Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Cardurion Pharmaceuticals

4.2 - Public trading comparable groups for Cardurion Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Cardurion Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Cardurion Pharmaceuticals

What does Cardurion Pharmaceuticals do?

Cardurion Pharmaceuticals is a provider of cardiovascular therapeutics and research services, developing a PDE9 inhibitor for HFrEF and HFpEF to enhance existing therapy; a CaMKII inhibitor for CPVT, heart failure, and atrial fibrillation; and conducting clinical trials, plus medicinal chemistry, computational molecular modeling, and genetic engineering support for cardiovascular research.

Who are Cardurion Pharmaceuticals's competitors?

Cardurion Pharmaceuticals's competitors and similar companies include CardiAQ Valve Technologies, Dezima Pharma, Conavi Medical, WR Medical, and Bellerophon Therapeutics.

Where is Cardurion Pharmaceuticals headquartered?

Cardurion Pharmaceuticals is headquartered in United States.

How many employees does Cardurion Pharmaceuticals have?

Cardurion Pharmaceuticals has 1,000 employees 🔒.

When was Cardurion Pharmaceuticals founded?

Cardurion Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Cardurion Pharmaceuticals in?

Cardurion Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Cardurion Pharmaceuticals

Who are the top strategic acquirers in Cardurion Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Cardurion Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Cardurion Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Cardurion Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Cardurion Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Cardurion Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Cardurion Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Cardurion Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Cardurion Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Cardurion Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Cardurion Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Cardurion Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Cardurion Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Cardurion Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Cardurion Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Cardurion Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Cardurion Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Cardurion Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Cardurion Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Cardurion Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Cardurion Pharmaceuticals

Launch login modal Launch register modal